Mosunetuzumab Monotherapy Demonstrates Encouraging Activity and a Manageable Safety Profile in Patients with Heavily Pre-Treated Relapsed or Refractory Mantle Cell LymphomaElizabeth Budde,Matthew Matasar,Laurie H. Sehn,Sarit E. Assouline,John Kuruvilla,Ian W. Flinn,Sung-Soo Yoon,Francesc Bosch,Daniel Greenwald,Norma C. Gutierrez,Dimitrios Tzachanis,Paula Marlton, Delaney Mcguirt,Shen Yin,Michael C. Wei,Antonia Kwan,Samuel Tracy,Elicia Penuel,Nancy L. BartlettBLOOD（2024）引用 0|浏览0AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
